The magnitude of the increase in the price of insulin over the years in the country is also staggering. According to an investigation by the House Oversight and Reform Committee that investigated pharmaceutical industry practices and was released in late 2021, Novo Nordisk’s NovoLog insulin, for example, has increased 627% since its launch, and Eli Lily’s Humalog has soared 1,219% since its launch.
